» Articles » PMID: 29222404

Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and MtDNA Levels in a Mouse Model of Parkinson's Disease

Overview
Journal J Neurosci
Specialty Neurology
Date 2017 Dec 10
PMID 29222404
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

is the most common gene mutated in monogenic recessive familial cases of Parkinson's disease (PD). Pathogenic mutations cause a loss of function of the encoded protein Parkin. ParkinKO mice, however, poorly represent human PD symptoms as they only exhibit mild motor phenotypes, minor dopamine metabolism abnormalities, and no signs of dopaminergic neurodegeneration. Parkin has been shown to participate in mitochondrial turnover, by targeting damaged mitochondria with low membrane potential to mitophagy. We studied the role of Parkin on mitochondrial quality control by knocking out Parkin in the PD-mito-I mouse (males), where the mitochondrial DNA (mtDNA) undergoes double-strand breaks only in dopaminergic neurons. The lack of Parkin promoted earlier onset of dopaminergic neurodegeneration and motor defects in the PD-mito-I mice, but it did not worsen the pathology. The lack of Parkin affected mitochondrial morphology in dopaminergic axons and was associated with an increase in mtDNA levels (mutant and wild type). Unexpectedly, it did not cause a parallel increase in mitochondrial mass or mitophagy. Our results suggest that Parkin affects mtDNA levels in a mitophagy-independent manner. Parkinson's disease is characterized by progressive motor symptoms due to the selective loss of dopaminergic neurons in the substantia nigra. Loss-of-function mutations of Parkin cause some monogenic forms of Parkinson's disease, possibly through its role in mitochondrial turnover and quality control. To study whether Parkin has a role in the context of mitochondrial damage, we knocked out Parkin in a mouse model in which the mitochondrial DNA is damaged in dopaminergic neurons. We found that the loss of Parkin did not exacerbate the parkinsonian pathology already present in the mice, but it was associated with an increase in mtDNA levels (mutant and wild-type) without altering mitochondrial mass. These results shed new light on the function of Parkin .

Citing Articles

Behavioral analysis of motor and non-motor impairment in rodent models of Parkinson's disease.

Sheta R, Berard M, Musiol D, Martinez-Drudis L, Oueslati A Front Aging Neurosci. 2025; 16:1464706.

PMID: 39763579 PMC: 11701160. DOI: 10.3389/fnagi.2024.1464706.


PARKIN is not required to sustain OXPHOS function in adult mammalian tissues.

Filograna R, Gerlach J, Choi H, Rigoni G, Barbaro M, Oscarson M NPJ Parkinsons Dis. 2024; 10(1):93.

PMID: 38684669 PMC: 11058849. DOI: 10.1038/s41531-024-00707-0.


Imaging Findings and Toxicological Mechanisms of Nervous System Injury Caused by Diquat.

Ren Y, Guo F, Wang L Mol Neurobiol. 2024; 61(11):9272-9283.

PMID: 38619744 PMC: 11496334. DOI: 10.1007/s12035-024-04172-x.


Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of α-synuclein and Parkin levels in rotenone-induced Parkinson's disease in rats.

Ahmed S, El-Sayed M, Kandeil M, Khalaf M Saudi Pharm J. 2022; 30(6):863-873.

PMID: 35812142 PMC: 9257853. DOI: 10.1016/j.jsps.2022.03.005.


The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.

Olesen M, Villavicencio-Tejo F, Quintanilla R Transl Neurodegener. 2022; 11(1):36.

PMID: 35787292 PMC: 9251940. DOI: 10.1186/s40035-022-00308-y.


References
1.
Grunewald A, Rygiel K, Hepplewhite P, Morris C, Picard M, Turnbull D . Mitochondrial DNA Depletion in Respiratory Chain-Deficient Parkinson Disease Neurons. Ann Neurol. 2015; 79(3):366-78. PMC: 4819690. DOI: 10.1002/ana.24571. View

2.
Matsuura K, Kabuto H, Makino H, Ogawa N . Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion. J Neurosci Methods. 1997; 73(1):45-8. DOI: 10.1016/s0165-0270(96)02211-x. View

3.
Flinn L, Mortiboys H, Volkmann K, Koster R, Ingham P, Bandmann O . Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio). Brain. 2009; 132(Pt 6):1613-23. DOI: 10.1093/brain/awp108. View

4.
Kim K, Stevens M, Akter M, Rusk S, Huang R, Cohen A . Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells. J Clin Invest. 2011; 121(9):3701-12. PMC: 3171101. DOI: 10.1172/JCI44736. View

5.
Kageyama Y, Zhang Z, Roda R, Fukaya M, Wakabayashi J, Wakabayashi N . Mitochondrial division ensures the survival of postmitotic neurons by suppressing oxidative damage. J Cell Biol. 2012; 197(4):535-51. PMC: 3352955. DOI: 10.1083/jcb.201110034. View